Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Jasbir Moore is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
IRP2 As A Potential Modulator Of Cell Proliferation, Apoptosis And Prognosis In Non Small Cell Lung Cancer
Khiroya, H., Moore, J., Ahmad, N., Kay, J., Woolnough, K., Langman, G., Ismail, I., Naidu, B., Tselepis, C. & Turner, A., 2017, In: European Respiratory Journal. 49, 1600711.Research output: Contribution to journal › Article › peer-review
Open AccessFile15 Citations (Scopus)239 Downloads (Pure) -
Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function
Quinkler, M., Zehnder, D., Lepenies, J., Petrelli, M., Moore, J., Hughes, S., Cockwell, P., Hewison, M. & Stewart, P., 1 Aug 2005, In: European Journal of Endocrinology. 153, 2, p. 291-299 9 p.Research output: Contribution to journal › Article
31 Citations (Scopus) -
PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro
Boelaert, K., Yu, R., Tannahill, L., Stratford, A., Khanim, F., Eggo, M., Moore, J., Young, L., Gittoes, N., Franklyn, J., Melmed, S. & McCabe, C., 3 Sept 2004, In: Journal of Molecular Endocrinology. 33, 3, p. 663-677 15 p.Research output: Contribution to journal › Article
33 Citations (Scopus) -
Weight loss increases 11 beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue
Tomlinson, J., Moore, J., Clark, P., Holder, G., Shakespeare, L. & Stewart, P., 1 Jan 2004, In: Journal of Clinical Endocrinology and Metabolism. 89, 6, p. 2711-2716 6 p.Research output: Contribution to journal › Article
72 Citations (Scopus) -
Suppression of vitamin D signalling in breast cancer cells involves silencing of p21 (WAF1/CIP1) through aberrant histone deactylase activity
Moore, J., O'Neill, L., Turner, B., Campbell, M. & Banwell, C., 1 Jan 2003, p. 83-98. 16 p.Research output: Contribution to conference (unpublished) › Paper